South Korea's Disgraced Scientist Goes Into Pet-Cloning Business
By Associated Press,
Associated Press
| 05. 14. 2008
SEOUL, South Korea — Disgraced South Korean stem cell scientist Hwang Woo-suk has set up a bio-technology firm specializing in cloning pet animals, a scientist close to Hwang said Wednesday.
Hwang, whose breakthrough human cloning research was later proved to be faked, recently established a new research firm in Seoul, said Park Se-pill, a Cheju National University professor and well-known stem cell scientist. Park said he spoke with Hwang a few days ago.
"He told me that he needs foreign capital to continue his research, but it's difficult to get it unless he sets up a new research institute and becomes its head," Park said.
Last month, the Korean Customs Service unveiled seven cloned Labrador retrievers being trained near Incheon International Airport, west of Seoul, to sniff out drugs and explosives.
The cloning work was conducted by a team of Seoul National University scientists who in 2005 successfully created the world's first known dog clone, an Afghan hound named "Snuppy."
The team is led by Professor Lee Byeong-chun, who was a key aide to Hwang.
South Korea's Yonhap News Agency...
Related Articles
By Evelina Johansson Wilén, Jacobin | 01.18.2026
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the one hand, it is deeply transformative, bodily alien, sometimes almost incomprehensible to the person undergoing it. On the other hand...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By Paula Siverino Bavio, BioNews | 01.12.2026
For more than ten years, gestational surrogacy in Uruguay existed in a state of legal latency: provided for by law, carefully regulated as an exception, yet without a single birth to make it real.
That situation changed with the arrival...